ADX-038 Dose Level 2

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase 2 Study of ADX-038 in Complement-Mediated Kidney DiseaseNCT06989359ADRXPhase 2Recruiting2030-04-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.